BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Terrazzini N, Kern F. Cell-mediated immunity to human CMV infection: a brief overview. F1000Prime Rep 2014;6:28. [PMID: 24860650 DOI: 10.12703/P6-28] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Cui X, Freed DC, Wang D, Qiu P, Li F, Fu TM, Kauvar LM, McVoy MA. Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells. J Virol 2017;91:e01650-16. [PMID: 28381568 DOI: 10.1128/JVI.01650-16] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
2 Fonseca S, Pereira V, Lau C, Teixeira MDA, Bini-Antunes M, Lima M. Human Peripheral Blood Gamma Delta T Cells: Report on a Series of Healthy Caucasian Portuguese Adults and Comprehensive Review of the Literature. Cells 2020;9:E729. [PMID: 32188103 DOI: 10.3390/cells9030729] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
3 Barnes S, Schilizzi O, Audsley KM, Newnes HV, Foley B. Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV). Int J Mol Sci 2020;21:E8864. [PMID: 33238550 DOI: 10.3390/ijms21228864] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Roshan R, Labo N, Trivett M, Miley W, Marshall V, Coren L, Cornejo Castro EM, Perez H, Holdridge B, Davis E, Matus-Nicodemos R, Ayala VI, Sowder R 2nd, Wyvill KM, Aleman K, Fennessey C, Lifson J, Polizzotto MN, Douek D, Keele B, Uldrick TS, Yarchoan R, Ohlen C, Ott D, Whitby D. T-cell responses to KSHV infection: a systematic approach. Oncotarget 2017;8:109402-16. [PMID: 29312617 DOI: 10.18632/oncotarget.22683] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
5 Lučin P, Mahmutefendić H, Blagojević Zagorac G, Ilić Tomaš M. Cytomegalovirus immune evasion by perturbation of endosomal trafficking. Cell Mol Immunol 2015;12:154-69. [PMID: 25263490 DOI: 10.1038/cmi.2014.85] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
6 Almishaal AA, Mathur PD, Hillas E, Chen L, Zhang A, Yang J, Wang Y, Yokoyama WM, Firpo MA, Park AH. Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice. PLoS Pathog 2017;13:e1006599. [PMID: 28859161 DOI: 10.1371/journal.ppat.1006599] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
7 Alston CI, Dix RD. SOCS and Herpesviruses, With Emphasis on Cytomegalovirus Retinitis. Front Immunol 2019;10:732. [PMID: 31031749 DOI: 10.3389/fimmu.2019.00732] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
8 Schlott F, Steubl D, Hoffmann D, Matevossian E, Lutz J, Heemann U, Hösel V, Busch DH, Renders L, Neuenhahn M. Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs. PLoS One 2017;12:e0171035. [PMID: 28129395 DOI: 10.1371/journal.pone.0171035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Elder E, Krishna B, Williamson J, Aslam Y, Farahi N, Wood A, Romashova V, Roche K, Murphy E, Chilvers E, Lehner PJ, Sinclair J, Poole E. Monocytes Latently Infected with Human Cytomegalovirus Evade Neutrophil Killing. iScience 2019;12:13-26. [PMID: 30677738 DOI: 10.1016/j.isci.2019.01.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
10 Chen D, Zhao R, Cao W, Zhou W, Jiang Y, Zhang S, Chen Y, Fei G, Li J, Qian J. Clinical characteristics of cytomegalovirus gastritis: A retrospective study from a tertiary medical center. Medicine (Baltimore) 2020;99:e18927. [PMID: 32000406 DOI: 10.1097/MD.0000000000018927] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
12 Alonso-Álvarez S, Colado E, Moro-García MA, Alonso-Arias R. Cytomegalovirus in Haematological Tumours. Front Immunol 2021;12:703256. [PMID: 34733270 DOI: 10.3389/fimmu.2021.703256] [Reference Citation Analysis]
13 Saavedra D, Garcia B, Lage A. T Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies. Front Immunol 2017;8:146. [PMID: 28261208 DOI: 10.3389/fimmu.2017.00146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
14 Nalwoga A, Roshan R, Moore K, Marshall V, Miley W, Labo N, Nakibuule M, Cose S, Rochford R, Newton R, Whitby D. Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nat Commun 2021;12:7323. [PMID: 34916520 DOI: 10.1038/s41467-021-27623-8] [Reference Citation Analysis]
15 Campos CF, Leite L, Pereira P, Vaz CP, Branca R, Campilho F, Freitas F, Ligeiro D, Marques A, Torrado E, Silvestre R, Lacerda JF, Campos A Jr, Cunha C, Carvalho A. PTX3 Polymorphisms Influence Cytomegalovirus Reactivation After Stem-Cell Transplantation. Front Immunol 2019;10:88. [PMID: 30766534 DOI: 10.3389/fimmu.2019.00088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Chanouzas D, Small A, Borrows R, Ball S. Assessment of the T-SPOT.CMV interferon-γ release assay in renal transplant recipients: A single center cohort study. PLoS One 2018;13:e0193968. [PMID: 29558479 DOI: 10.1371/journal.pone.0193968] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
17 Cox M, Adetifa JU, Noho-Konteh F, Sanyang LC, Drammeh A, Plebanski M, Whittle HC, Rowland-Jones SL, Robertson I, Flanagan KL. Sex-Differential Impact of Human Cytomegalovirus Infection on In Vitro Reactivity to Toll-Like Receptor 2, 4 and 7/8 Stimulation in Gambian Infants. Vaccines (Basel) 2020;8:E407. [PMID: 32707906 DOI: 10.3390/vaccines8030407] [Reference Citation Analysis]
18 Freer G, Quaranta P, Pistello M. Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission. J Immunol Res 2016;2016:9384813. [PMID: 28044143 DOI: 10.1155/2016/9384813] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
19 Effros RB. The silent war of CMV in aging and HIV infection. Mech Ageing Dev 2016;158:46-52. [PMID: 26404009 DOI: 10.1016/j.mad.2015.09.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
20 El Baba R, Herbein G. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation. Front Immunol 2021;12:730765. [PMID: 34566995 DOI: 10.3389/fimmu.2021.730765] [Reference Citation Analysis]
21 Proff J, Walterskirchen C, Brey C, Geyeregger R, Full F, Ensser A, Lehner M, Holter W. Cytomegalovirus-Infected Cells Resist T Cell Mediated Killing in an HLA-Recognition Independent Manner. Front Microbiol 2016;7:844. [PMID: 27375569 DOI: 10.3389/fmicb.2016.00844] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]